EC
TNDM icon

EntryPoint Capital’s Tandem Diabetes Care TNDM Stock Holding History

EntryPoint Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,477
Closed -$208K – 920
2025
Q4 		$208K Buy
+9,477
New +$171K 0.08% 536
2025
Q1 		– Sell
-8,167
Closed -$294K – 949
2024
Q4 		$294K Buy
+8,167
New +$276K 0.12% 377
2024
Q3 		– Sell
-926
Closed -$37.3K – 1327
2024
Q2 		$37.3K Buy
+926
New +$38.6K 0.02% 1148

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

EntryPoint Capital's TNDM Position: Q1 2026 in Review

EntryPoint Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 9,477 shares — an estimated $208K sold.

EntryPoint Capital first reported a position in TNDM in Q2 2024 and held it in 3 quarters. The position peaked at $294K in Q4 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • EntryPoint Capital reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 9,477 Tandem Diabetes Care shares in Q1 2026, an estimated $208K.
  • EntryPoint Capital first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 3 quarters.
  • EntryPoint Capital's Tandem Diabetes Care position peaked at $294K in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.